Elucidating roles and mechanisms of double-stranded RNA-mediated pathways
阐明双链RNA介导途径的作用和机制
基本信息
- 批准号:10594483
- 负责人:
- 金额:$ 60.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AnimalsAntiviral ResponseBinding ProteinsBiochemicalBiochemistryCaenorhabditis elegansDeaminationDicer EnzymeDouble-Stranded RNAEnabling FactorsEnzymesGene SilencingGenetic ScreeningGoalsHealthHumanImmuneImmune responseIn VitroInnate Immune ResponseInterferonsInvertebratesKineticsKnowledgeMammalsMediatingMolecularMolecular MotorsPathway interactionsProcessProteinsRNARNA EditingRNA InterferenceRNA Interference PathwayResearchRoleSiteSmall RNAVertebratesViraldesigndsRNA adenosine deaminasefascinatehelicasein vivo evaluationinsightmodel organismstructural biologyviral RNA
项目摘要
SUMMARY/ABSTRACT
The goal of the proposed research is to define and characterize the long double-stranded RNA (dsRNA) encoded
and expressed in animals, including humans, and the proteins that bind, modify, and process this dsRNA. A key,
health-related, focus is how this endogenous dsRNA is discriminated from the long viral dsRNA that is recognized
as foreign to trigger an innate immune response. Recent studies show that in both vertebrates and invertebrates,
the RNA editing enzymes called Adenosine deaminases that act on RNA, or ADARs, deaminate endogenous
dsRNA so that it will not trigger an aberrant immune response. The mechanism by which ADARs, and the editing
sites they create, preclude activation of an innate immune response is unclear, and the proposed research is
designed to fill this gap in knowledge. Using genetic screens and molecular approaches, the model organism C.
elegans will be used to discover RNAs and proteins that lead to an immune response in strains lacking ADARs;
biochemical approaches will be used to provide in-depth mechanistic insights. While mammals use the interferon
pathway to mount an antiviral response, invertebrates lack this pathway, and instead, use RNA interference
(RNAi) in antiviral defense. The enzyme Dicer is key to the antiviral RNAi pathway and is essential for cleaving
viral dsRNA during the invertebrate immune response. Our prior in vitro studies indicate Dicer's helicase domain
recognizes the ends of viral dsRNA as “nonself”, or foreign, and the proposed studies are designed to test this
in vivo. The helicase domain of invertebrate Dicers is a fascinating molecular motor, and biochemistry, transient
kinetic analyses, and structural biology, will be used to understand how it coordinates dsRNA cleavage, and
ultimately passes small RNA products to downstream factors that enable gene silencing by the RNAi pathway.
Modulation of Dicer's activity by accessory factors that interact with the helicase domain will be investigated.
Differences in activities of the helicase domain of human Dicer and invertebrate Dicers will be explored to
understand how this enzyme evolved as the immune pathways of vertebrates and invertebrates diverged.
摘要/摘要
拟议研究的目标是定义和表征长双链 RNA (dsRNA) 编码的
并在包括人类在内的动物中表达,以及结合、修饰和加工该 dsRNA A key 的蛋白质。
与健康相关,重点是如何将这种内源性 dsRNA 与已识别的长病毒 dsRNA 区分开来
最近的研究表明,在脊椎动物和无脊椎动物中,
RNA 编辑酶(称为腺苷脱氨酶)作用于 RNA(或 ADAR),使内源性脱氨
dsRNA,使其不会触发异常的免疫反应 ADAR 的机制以及编辑。
他们创建的位点,阻止先天免疫反应的激活尚不清楚,拟议的研究是
旨在利用遗传筛选和分子方法填补这一知识空白,模型生物 C.
线虫将被用来发现 RNA 和蛋白质,从而在缺乏 ADAR 的菌株中产生免疫反应;
当哺乳动物使用干扰素时,生化方法将用于提供深入的机制见解。
产生抗病毒反应的途径,无脊椎动物缺乏该途径,而是使用 RNA 干扰
(RNAi) 抗病毒防御中的酶 Dicer 是抗病毒 RNAi 途径的关键,对于裂解至关重要。
我们之前的体外研究表明 Dicer 的解旋酶结构域。
将病毒 dsRNA 的末端识别为“非自身”或外源,拟议的研究旨在测试这一点
无脊椎动物 Dicers 的解旋酶结构域是一种令人着迷的分子马达,并且在生物化学中是短暂的。
动力学分析和结构生物学将用于了解它如何协调 dsRNA 切割,以及
最终将小RNA产物传递给下游因子,从而通过RNAi途径实现基因沉默。
将研究与解旋酶结构域相互作用的辅助因子对 Dicer 活性的调节。
将探索人类 Dicer 和无脊椎动物 Dicer 解旋酶结构域活性的差异
了解这种酶如何随着脊椎动物和无脊椎动物的免疫途径的分歧而进化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brenda L. Bass其他文献
Activation of PKR by a short-hairpin RNA
短发夹 RNA 激活 PKR
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Kyle A. Cottrell;Sua Ryu;H. Donelick;Hung Mai;Jackson R. Pierce;Brenda L. Bass;Jason D. Weber - 通讯作者:
Jason D. Weber
Brenda L. Bass的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brenda L. Bass', 18)}}的其他基金
Elucidating roles and mechanisms of double-stranded RNA-mediated pathways
阐明双链RNA介导途径的作用和机制
- 批准号:
10795249 - 财政年份:2021
- 资助金额:
$ 60.39万 - 项目类别:
Elucidating roles and mechanisms of double-stranded RNA-mediated pathways
阐明双链RNA介导途径的作用和机制
- 批准号:
10380082 - 财政年份:2021
- 资助金额:
$ 60.39万 - 项目类别:
Elucidating roles and mechanisms of double-stranded RNA-mediated pathways
阐明双链RNA介导途径的作用和机制
- 批准号:
10189022 - 财政年份:2021
- 资助金额:
$ 60.39万 - 项目类别:
Unlocking evolutionarily latent immune functions for treating disease
解锁进化上潜在的免疫功能来治疗疾病
- 批准号:
10021943 - 财政年份:2020
- 资助金额:
$ 60.39万 - 项目类别:
Unlocking evolutionarily latent immune functions for treating disease
解锁进化上潜在的免疫功能来治疗疾病
- 批准号:
10240664 - 财政年份:2020
- 资助金额:
$ 60.39万 - 项目类别:
Unlocking evolutionarily latent immune functions for treating disease
解锁进化上潜在的免疫功能来治疗疾病
- 批准号:
10700046 - 财政年份:2020
- 资助金额:
$ 60.39万 - 项目类别:
Cellular double-stranded RNA as a signal of stress, immunity, and aging.
细胞双链 RNA 作为压力、免疫和衰老的信号。
- 批准号:
8706759 - 财政年份:2011
- 资助金额:
$ 60.39万 - 项目类别:
Cellular double-stranded RNA as a signal of stress, immunity, and aging.
细胞双链 RNA 作为压力、免疫和衰老的信号。
- 批准号:
8142547 - 财政年份:2011
- 资助金额:
$ 60.39万 - 项目类别:
Cellular double-stranded RNA as a signal of stress, immunity, and aging.
细胞双链 RNA 作为压力、免疫和衰老的信号。
- 批准号:
8331579 - 财政年份:2011
- 资助金额:
$ 60.39万 - 项目类别:
Cellular double-stranded RNA as a signal of stress, immunity, and aging.
细胞双链 RNA 作为压力、免疫和衰老的信号。
- 批准号:
8520153 - 财政年份:2011
- 资助金额:
$ 60.39万 - 项目类别:
相似国自然基金
溶质载体SLC38A10调控抗病毒天然免疫反应的作用及分子机制
- 批准号:32370926
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
RNA分子SNORA31结合cGAS并调控小胶质细胞的抗病毒天然免疫反应的作用与机制研究
- 批准号:82301981
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于HEV介导炎症反应与干扰素通路信号交互机制的抗病毒策略研究
- 批准号:82370610
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
鲫TRAF6负调控干扰素抗病毒免疫反应的分子机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
去乙酰化酶SIRT1在抗病毒固有免疫反应中的调控作用及相关机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Broadly neutralizing SARS-CoV-2 peptidic knobs
广泛中和 SARS-CoV-2 肽旋钮
- 批准号:
10735902 - 财政年份:2023
- 资助金额:
$ 60.39万 - 项目类别:
MultiOMICS mechanistic identification of predictors of HIV DNA decay, restoration of immune homeostasis and HIV specific immunity in PWH with cancer receiving Immune check point therapy
接受免疫检查点治疗的癌症患者中 HIV DNA 衰变、免疫稳态恢复和 HIV 特异性免疫的预测因子的多组学机制鉴定
- 批准号:
10731665 - 财政年份:2023
- 资助金额:
$ 60.39万 - 项目类别:
Innate immunity against viral infection in intestinal epithelial cells of C. elegans
秀丽隐杆线虫肠上皮细胞对病毒感染的先天免疫
- 批准号:
10680767 - 财政年份:2023
- 资助金额:
$ 60.39万 - 项目类别:
Hepatoselective Dihydroquinolizinone (HS-DHQ) Molecules for Treatment and Prevention of Hepatitis A Virus (HAV) Infection
用于治疗和预防甲型肝炎病毒 (HAV) 感染的肝选择性二氢喹嗪酮 (HS-DHQ) 分子
- 批准号:
10698516 - 财政年份:2023
- 资助金额:
$ 60.39万 - 项目类别:
Zika virus nonstructural protein 5 inhibition of interferon signaling
寨卡病毒非结构蛋白 5 对干扰素信号传导的抑制
- 批准号:
10641222 - 财政年份:2023
- 资助金额:
$ 60.39万 - 项目类别: